Year To Quarter End Consolidated Statement Of Income

Delta-Fly Pharma, Inc. - Filing #7710878

Concept 2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
Year to quarter end consolidated statement of income
Statement of income
Selling, general and administrative expenses
Remuneration for directors (and other officers)
48,420,000 JPY
49,047,000 JPY
Taxes and dues
36,098,000 JPY
9,762,000 JPY
Operating profit (loss)
-592,523,000 JPY
-243,818,000 JPY
Non-operating income
Interest income
283,000 JPY
222,000 JPY
Non-operating income
806,000 JPY
805,000 JPY
Non-operating expenses
Interest expenses
312,000 JPY
442,000 JPY
Non-operating expenses
79,495,000 JPY
1,492,000 JPY
Ordinary profit (loss)
-671,213,000 JPY
-244,505,000 JPY
Profit (loss) before income taxes
-671,213,000 JPY
-244,505,000 JPY
Income taxes - current
2,543,000 JPY
1,762,000 JPY
Income taxes
2,543,000 JPY
1,762,000 JPY
Profit (loss)
-673,756,000 JPY
-673,756,000 JPY
-673,756,000 JPY
-673,756,000 JPY
-246,268,000 JPY
-246,268,000 JPY
-246,268,000 JPY
-246,268,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.